IAM
Iambic Therapeutics Inc.
There isn't enough reported data to score IAM yet.
IAM Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate IAM's fundamentals.
IAM PE Valuation
IAM has no meaningful PE right now: it lost money over the past year.
IAM Forward outlook
There aren't enough analyst estimates for IAM to show an outlook.
IAM Earnings Per Share
IAM Quarterly Revenue
IAM Free Cash Flow
IAM Net Leverage
IAM's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
IAM Weekly Momentum
As of the close on Nov 12, 2026: $14.84.
IAM PE vs Healthcare Sector
IAM has no meaningful PE right now: it lost money over the past year.
IAM Weekly Moving Averages
As of the close on Nov 12, 2026: $14.84.
IAM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $23.8 | $14.8 | -38% |
It's down 38% so far in 2026.